Literature DB >> 32930745

Oral Drug Approved for Spinal Muscular Atrophy.

Mary Chris Jaklevic.   

Abstract

Entities:  

Year:  2020        PMID： 32930745     DOI： 10.1001/jama.2020.16783

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  3 in total

Review 1.  The why behind the high: determinants of neurocognition during acute cannabis exposure.

Authors:  Johannes G Ramaekers; Natasha L Mason; Lilian Kloft; Eef L Theunissen
Journal:  Nat Rev Neurosci       Date:  2021-05-27       Impact factor: 34.870

Review 2.  Inhibition of SARS-CoV-2 by Targeting Conserved Viral RNA Structures and Sequences.

Authors:  Shalakha Hegde; Zhichao Tang; Junxing Zhao; Jingxin Wang
Journal:  Front Chem       Date:  2021-12-23       Impact factor: 5.221

Review 3.  The Contribution of COL4A5 Splicing Variants to the Pathogenesis of X-Linked Alport Syndrome.

Authors:  Tomohiko Yamamura; Tomoko Horinouchi; Yuya Aoto; Rachel Lennon; Kandai Nozu
Journal:  Front Med (Lausanne)       Date:  2022-02-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.